By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Medical InnovationsNewsTechnology

Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

Avita Medical Limited (ASX: AVH) is a publicly traded global medical technology company trading on the Australian Stock Exchange. It develops, distributes and commercializes regenerative medicine products.

Avita Medical Limited (ASX: AVH) is a publicly traded global medical technology company trading on the Australian Stock Exchange. It develops, distributes and commercializes regenerative medicine products.

Avita’s clinically tested, tissue-engineered product, ReCell, provides revolutionary solutions utilizing the patient’s own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. Most recently, the company has announced the product’s proven ability to treat chronic leg ulcers.

ReCell is a spray-on, stand-alone rapid cell harvesting device, which enables surgeons to treat skin defects using the patient’s own cells. The product allows for the surgeon to prepare a small quantity of cells within 30 minutes on site. The metabolic cells, then migrate across the surface of the wound, creating regenerative skin of normal color and texture. ReCell has been designed for use in a wide variety of burns, plastic, reconstructive and cosmetic procedures. It can replace the current technique of skin grafting.

More Read

Big Tobacco is Still Targeting Our Kids
Can Bitcoin Really Work in The Healthcare Industry?
Will Technology Replace Doctors? Not So Soon!
6 Lessons from the World Cup for Medical Device Companies
The Walking Gallery at HealthData and Information Week – Storified

According to a presentation given by Dr Giuliano Magi, M.D., and colleagues, “Autologous transplantation of epidermal cells is difficult to treat ulcers of the lower limbs.”  Out of 10 patients whom were suffering from unhealed chronic ulcers, 1 was lost due to an unrelated incident, 8 achieved 100% healing and 1 achieved 90% re-epithelialization after a 4 week period.

Dr. Magi stated, “ReCell has demonstrated a very high success rate in the treatment of chronic leg ulcers. Although we have only a limited sample size, the outcomes in these recalcitrant ulcers are clinically outstanding and cost-effective for the healthcare system. Furthermore patients report an immediate decrease in pain and are resuming normal activities straight after the ReCell procedure making it more acceptable to the patients themselves.”

Treating chronic leg ulcers alone is a market estimated at $1 billion. More thank 3,500 patients have been treated with ReCell for injuries such as, burns, hypo and hyper-pigmentation, scarring and wrinkle removal. Over the last year, revenues have increased 29%, and sales have increased about 150%. Management expects this trend to continue, with regenerative products contributing an increasing proportion of sales revenues.

“Sales of our ReCell Spray‐On‐Skin regenerative product have shown strong growth, not only year‐to‐year and quarter‐to‐quarter but also in consecutive quarters,” said William Dolphin, Ph.D., CEO of Avita Medical. “ReCell is an easy-to-use bedside kit that is now available to clinicians in Australia, France, Germany, Portugal, Russia, The Netherlands and the United Kingdom.”

In addition to regenerative treatments, Avita also commercializes medical technologies for improved medication delivery and adherence in patients suffering from chronic respiratory diseases.

Avita Medical Limited will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Innovation without Diligence Negatively Impacts Healthcare Access

January 4, 2012

The FDA Patient Network Website: Pretty Darn Patient-Centered

May 15, 2013
Image
News

The History of the Nurse’s Cap

May 9, 2012

New Test Predicts Which Cancers will Spread

March 10, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?